Repeat-Dose Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers.
Phase of Trial: Phase I/II
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Cytisine (Primary)
- Indications Smoking withdrawal
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Achieve Life Sciences
- 04 Oct 2017 According to an Achieve Life Sciences media release, the company has initiated this trial to support a pivotal Phase 3 trial in the United States (see profile 700287776). This study is expected to be completed by the end of the year, with data expected by the first-quarter of 2018.
- 04 Oct 2017 Status changed from not yet recruiting to recruiting, as reported in an Achieve Life Sciences media release.
- 17 Aug 2017 New trial record